Overlap syndrome - asthma and chronic obstructive pulmonary disease;Zespół "nakładania" astmy i przewlekłej obturacyjnej choroby płuc

Pneumonologia i Alergologia Polska

Volumn 79, Issue 5, 2011, Pages 351-356

  Płusa, Tadeusz ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Asthma; COPD; Diagnosis; Overlap syndrome; Remodeling; Risk factors; Small airways

Indexed keywords

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; HOSPITALIZATION; HUMAN; LUNG FUNCTION TEST; LUNG VENTILATION; PATHOPHYSIOLOGY;

ASTHMA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 80052076379     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Sluiter H.J., Koeter G.H., de Monchy J.G., Postma D.S., de Vries K., Orie N.G. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur. Respir. J. 1991; 4: 479-489.
2. Orie N.G.M., Sluiter H.J., de Vries K. The host factor in bronchitis. W: Orie N.G.M., Sluiter H.J. (red.). Bronchitis an International Symposium, Assen, Netherlands. Royal van Gorcum; 1961.
3. Magnussen H., Richter K., Taube C. Are chronic obstructive pulmonary disease (COPD) and asthma different diseases? Clin. Exp. Allergy 1998; 28 (supl. 5): 187-194; dyskusja 203-205.
4. Welte T., Groneberg D.A. Asthma and COPD. Exp. Toxicol. Pathol. 2006; 57 (supl. 2): 35-40.
5. Celli B.R., Halbert R.J., Isonaka S., Schau B. Population impact of different definitions of airway obstruction. Eur. Respir. J. 2003; 22: 268-273.
6. Soriano J.B., Davis K.J., Coleman B., Visick G., Mannino D., Pride N.B. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
7. Abramson M., Matheson M., Wharton C., Sim M., Walters E.H. Prevalence of respiratory symptoms related to chronic obstructive pulmonary disease and asthma among middle aged and older adults. Respirology 2002; 7: 325-331.
8. Cerveri I., Accordini S., Corsico A. I wsp. Chronic cough and phlegm in young adults. Eur. Respir. J. 2003; 22: 413-417.
9. Shaya F.T., Dongyi D., Akazawa M.O. I wsp. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008; 134: 14-19.
10. Burrows B., Knudson R.J., Lebowitz M.D. The relationship of childhood wheezy bronchitis illness to adult obstructive airway disease. Am. Rev. Respir. Dis. 1977; 115: 751-760.
11. Guera S., Wright A.L., Morgan W.J., Sherrill D.L., Holberg C.J., Martinez F.D. Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty. Am. J. Respir. Crit. Care Med. 2004; 170: 78-85.
12. Horak E., Lanigan A., Roberts M. I wsp. Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. Br. Med. J. 2003; 326: 422-423.
13. Sears M.R., Greene J.M., Wilan A.R. I wsp. A longitudinal population-based, cohort study of childhood asthma followed to adulthood. N. Engl. J. Med. 2003; 349: 1414-1422.
14. Silva G.E., Sherrill D.L., Guera S., Barbee R.A. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126: 59-65.
15. Vonk J.M., Jangepier H., Panhuysen C.I., Schouten J.P., Bleeck-er E.R., Postma D.S. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58: 322-327.
16. Sciurba F.C. Physiologic similarities and differences between COPD and asthma. Chest 2004; 126 (supl. 2): 117S-124S; dys-kusja 159S-161S.
17. Sköld C.M. Remodeling in asthma and COPD - differences and similarities. Clin. Respir. J. 2010; 4 (supl. 1): 20-27.
18. Płusa T. Współczesna strategia oraz zasady leczenia chorych na POChP. Pol. Merkur. Lek. 2009; 27: 447-452.
19. Lee Y.M., Park J.S., Hwang J.H. High-resolution CT findings in patients with near-fatal asthma: comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004; 126: 1840-1848.
20. Scichilone N., Battaglia S., Olivieri D., Bellia V. The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1? Allergy 2009; 64: 1563-1569.
21. Buist A.S. Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes. Eur. Respir. J. Suppl. 2003; 39: 30s-35s.
22. Corren J. Small airways disease in asthma. Curr. Allergy Asthma Rep. 2008; 8: 533-539.
23. Virchow J.C. Asthma - a small airway disease: concepts and evidence. Pneumologie 2009; 63 (supl. 2): S96-S101.
24. Fabbri L.M., Nicolini G., Olivieri D., Papi A. Inhaled beclometa-sone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives. Expert Opin. Pharmacother. 2008; 9: 479-490.
25. Reid D.W., Soltani A., Johns D.P. I wsp. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Intern. Med. J. 2003; 33: 572-577.
26. Sitkauskiene B., Sakalauskas R., Malakauskas K., Lötvall J. Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation. Respir. Med. 2003; 97: 591-598.
27. Lapperre T.S., Snoeck-Stroband J.B., Gosman M.M. I wsp. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 170: 499-504.
28. Busse W., Banks-Schlegel S., Noel P., Ortega H., Taggart V., Elias J. NHLBI Working Group: Future research directions in asthma: an NHLBI Working Group report. Am. J. Respir. Crit. Care Med. 2004; 170: 683-690.
29. Jeffery P.K. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 2001; 164: S28-S38.
30. Jeffery P.K. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2004; 1: 176-183.
31. Romagnoli M., Vachier I., de la Torodo Fuente P. I wsp. Eosino-philic inflammation in sputum of poorly controlled asthmatics. Eur. Respir. J. 2002; 20: 1370-1377.
32. Green R.H., Brighting C.E., McKenna S. I wsp. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002; 360: 1715-1721.
33. Keatings V.M., Jatakonon A., Worsdell Y.M., Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 1997; 155: 542-548.
34. Stankiewicz W., Dabrowski M.P., Chcialowski A., Plusa T. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma. Mediat. Inflamm. 2002; 11: 307-312.
35. Saetta M., Turato G., Maestrelli P., Mapp C.E., Fabbri L.M. Cellular and structural bases of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 163: 1304-1309.
36. Gono H., Fujimoto K., Kawakami S., Kubo K. Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma. Eur. Respir. J. 2003; 22: 956-971.
37. Mitsunobu F., Ashida K., Hosaki Y. I wsp. Complexity of terminal airspace geometry assessed by computed tomography in asthma. Am. J. Respir. Crit. Care Med. 2003; 167: 411-417.
38. Gibson P.G., Simpson J.L. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-735.
39. Wilson J.W. Inflammation and remodelling in the ageing airway. Med. J. Aust. 2005; 183 (supl. 1): S33-S34.
40. Kato M., Makita H., Uemura K. I wsp. Bronchodilator efficacy of single doses of indacaterol in Japaneese patients with COPD: a randomized, double-blind, placebo-controlled trial. Allergol. Internat. 2010; 59: 1-9.
41. Stoeck M., Riedel R., Hochhaus G. I wsp. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J. Pharmacol. Exp. Ther. 2004; 309: 249-258.